Inhibition of NMDA-induced striatal dopamine release and behavioral activation by the neuroactive steroid 3α-hydroxy-5β-pregnan-20-one hemisuccinate

Journal of Neurochemistry

Volumn 86, Issue 1, 2003, Pages 92-101

  Sadri Vakili, G ^a   Johnson, D W ^b   Janis, G C ^a   Gibbs, T T ^a   Pierce, R C ^a   Farb, David H ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEW ENGLAND   (United States)

Author keywords

Dopamine; Microdialysis; Modulator; Neuroactive steroid; NMDA receptor; Striatum

Indexed keywords

3ALPHA HYDROXY 5BETA PREGNAN 20 ONE HEMISUCCINATE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROSTEROID; UNCLASSIFIED DRUG;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOPAMINE RELEASE; MALE; MENTAL DISEASE; MOTOR ACTIVITY; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SEDATION; STRIATE CORTEX;

ANIMALS; BEHAVIOR, ANIMAL; CORPUS STRIATUM; DOPAMINE; EXCITATORY AMINO ACID AGONISTS; INJECTIONS, INTRAPERITONEAL; MALE; MICRODIALYSIS; MICROINJECTIONS; MOTOR ACTIVITY; N-METHYLASPARTATE; PREGNANOLONE; RATS; RATS, SPRAGUE-DAWLEY; STEROIDS; SUCCINATES;

ANIMALIA;

EID: 0038308515     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.01814.x     Document Type: Article

References (64)

1. Authier N., Dupuis E., Kwasiborski A., Eschalier A. and Coudore F. (2002) Behavioural assessment of dimethylsulfoxide neurotoxicity in rats. Toxicol. Lett. 132, 117-121.
2. Baulieu E. E. (1998) Neurosteroids: a novel function of the brain. Psychoneuroendocrinology 23, 963-987.
3. Bowlby M. (1993) Pregnenolone sulfate potentiation of N-methyl-D-aspartate receptor channels in hippocampal neurons. Mol. Pharmacol. 43, 813-819.
4. Carlsson M. and Carlsson A. (1989) The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice. J. Neural Transm. 75, 221-226.
5. Carlsson M. and Carlsson A. (1990) Interactions between glutamatergic and monoaminergic systems within the basal ganglia: implications for schizophrenia and Parkinson's disease. Trends Neurosci. 13, 272-276.
6. Cheramy A., Romo R., Godehen G., Baruch P. and Glowinsky J. (1986) In vivo pre-synaptic control of dopamine release in the cat caudate nucleus. Facilitatory or inhibitory influence of glutamate. Neuroscience 19, 1081-1090.
7. Cheramy A., Barbeito L., Godeheu G., Desce J. M., Pittaluga A., Galli T., Artaud F. and Glowinski J. (1990) Respective contributions of neuronal activity and pre-synaptic mechanisms in the control of the in vivo release of dopamine. J. Neural Transm. Suppl. 29, 183-193.
8. Cheramy A., Desce J. M., Godeheu G. and Glowinski J. (1994) Pre-synaptic control of dopamine synthesis and release by excitatory amino acids in rat striatal synaptosomes. Neurochem. Int. 25, 145-154.
9. Clow D. W. and Jhamandas K. (1989) Characterization of 1-glutamate action on the release of endogenous dopamine from the rat caudate-putamen. J. Pharmacol. Exp. Ther. 248, 722-728.
10. Desce J. M., Godeheu G., Galli T., Artaud F., Cheramy A. and Glowinski J. (1992) L-Glutamate-evoked release of dopamine from synaptosomes of the rat striatum: involvement of AMPA and N-methyl-D-aspartate receptors. Neuroscience 47, 333-339.
11. Desce J. M., Godeheu G., Galli T., Glowinski J. and Cheramy A. (1994) Opposite pre-synaptic regulations by glutamte through NMDA receptors of dopamine synthesis and release in rat striatal synaptosomes. Brain Res. 640, 205-214.
12. Dingledine R., Hynes M. A. and King G. L. (1986) Involvement of N-methyl-D-aspartate receptors in epileptiform bursting in the rat hippocampal slice. J. Physiol. 380, 175-189.
13. Galli T., Godeheu G., Artaud F., Desce J. M., Pittaluga A., Barbeito L., Glowsinki J. and Cheramy A. (1991) Specific role of N-acetyl-aspartyl-glutamate in the in vivo regulation of dopamine release from dendrites and nerve terminals of nigrostriatal dopaminergic neurons in the cat. Neuroscience 42, 19-28.
14. Greig N. H., Sweeney D. J. and Rapoport S. I. (1985) Inability of dimethyl sulfoxide to increase brain uptake of water-soluble compounds: implications to chemotherapy for brain tumors. Cancer Treat. Rep. 69, 305-312.
15. 3H]-dopamine from striatal slices. Neuroreport 3, 409-412.
16. Herron C. E., Lester R. A., Coan E. J. and Collingridge G. L. (1985) Intracellular demonstration of an N-methyl-D-aspartate receptor mediated component of synaptic transmission in the rat hippocampus. Neurosci. Lett. 60, 19-23.
17. Hurd Y. L. and Ungerstedt U. (1989) In vivo neurochemical profile of dopamine uptake inhibitors and releasers in rat caudate-putamen. Eur. J. Pharmacol. 166, 251-260.
18. Iravani M. M. and Kruk Z. L. (1996) Real-time effects of N-methyl-D-aspartic acid on dopamine release in slices of rat caudate putamen: a study using fast cyclic voltammetry. J. Neurochem. 66, 1076-1085.
19. 2+ in cultured rat hippocampal neurons. Neurosci. Lett. 141, 30-34.
20. 2+ responses: structure activity studies. J. Pharmacol. Exp. Ther. 271, 677-682.
21. Keefe K. A., Zigmond M. J. and Abercrombie E. D. (1992) Extracellular dopamine in striatum: influence of nerve impulse activity in medial forebrain bundle and local glutamatergic input. Neuroscience 47, 325-332.
22. Keefe K. A., Zigmond M. J. and Abercrombie E. D. (1993) In vivo regulation of extracellular dopamine in the neostriatum: influence of impulse activity and local excitatory amino acids. J. Neural Transm. General Sect. 91, 223-240.
23. Koek W., Woods J. H. and Winger G. D. (1988) MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys. J. Pharmacol. Exp. Ther. 245, 969-974.
24. Krebs M. O., Desce J. M., Kemel M. L., Gauchy C., Godeheu G., Cheramy A. and Glowinski J. (1991a) Glutamatergic control of dopamine release in the rat striatum: evidence for pre-synaptic N-methyl-D-aspartate receptors on dopaminergic nerve terminals. J. Neurochem. 56, 81-85.
25. Krebs M. O., Trovero F., Desban M., Gauchy C., Glowinski J. and Kemel M. L. (1991b) Distinct pre-synaptic regulation of dopamine release through NMDA receptors in striosome- and matrix-enriched areas of rat striatum. J. Neurosci. 11, 1256-1262.
26. Kuppenbender K. D., Standaert D. G., Feuerstein T. J., Penney J. B. Jr, Young A. B. and Landwehrmeyer G. B. (2000) Expression of NMDA receptor subunit mRNAs in neurochemically identified projection and interneurons in the human striatum. J. Comp. Neurol. 419, 407-421.
27. Lahti A. C., Koffel B., LaPorte D. and Tamminga C. A. (1995) Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 13, 9-19.
28. Landwehrmeyer G. B., Standaert D. G., Testa C. M., Penney J. B. Jr and Young A. B. (1995) NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum. J. Neurosci. 15, 5297-5307.
29. Malayev A., Gibbs T. T. and Farb D. H. (2002) Inhibition of the NMDA response by pregnenolone sulphate reveals subtype selective modulation of NMDA receptors by sulphated steroids. Br. J. Pharmacol. 135, 901-909.
30. Marek P., Chapman C. D. and Howard S. (1992) The effect of phencyclidine and DL-2-amino-5-phosphonovaleric acid on N-methyl-D-aspartic acid induced changes in extracellular concentration of dopamine and DOPAC in the rat neostriatum. Neuropharmacology 31, 123-127.
31. 3H]dopamine from rat brain in vitro: effects of opioids on release induced by potassium, nicotine, and 1-glutamic acid. Can J. Physiol. Pharmacol. 61, 43-60.
32. Martinez-Fong D., Rosales M. G., Gongora-Alfaro J. L., Hernandez S. and Aceves J. (1992) NMDA receptors mediates dopamine release in the striatum of unanesthetized rats as measured by brain microdialysis. Brain Res. 595, 309-315.
33. Moghaddam B., Roth R. H. and Bunney B. S. (1990) Characterization of dopamine release in the rat medial pre-frontal cortex as assessed by in vivo microdialysis: comparison to the striatum. Neuroscience 36, 669-676.
34. Morris R. G., Anderson E., Lynch G. S. and Baudry M. (1986) Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature 319, 774-776.
35. Neuwelt E. A., Barnett P., Barranger J., McCormick C., Pagel M. and Frenkel E. (1983) Inability of dimethyl sulfoxide and 5-fluorouracil to open the blood-brain barrier. Neurosurgery 12, 29-34.
36. Olney J. W., Labruyere J., Collins J. F. and Curry K. (1981) D-amino-phosphonovalerate is 100-fold more powerful than D-α-aminoadipate in blocking N-methyl-aspartate neurotoxicity. Brain Res. 221, 207-210.
37. Ossowska K. and Wolfarth S. (1995) Stimulation of glutamate receptors in the intermediate/caudal striatum induces contralateral turning. Eur J. Pharmacol. 273, 89-97.
38. Park-Chung M., Wu F. S. and Farb D. H. (1994) 3α-Hydroxy-5β-pregnan-20-one sulfate: a negative modulator at the NMDA receptor. Mol. Pharmacol. 46, 146-150.
39. Park-Chung M., Wu F. S., Purdy R. H., Malayev A. A., Gibbs T. T. and Farb D. H. (1997) Distinct sites for inverse modulation of NMDA receptors by sulfated steroids. Mol. Pharmacol. 52, 1113-1123.
40. Paul S. M. and Purdy R. H. (1992) Neuroactive steroids. FASEB J. 6, 2311-2322.
41. Paxinos G. and Watson C. (1997) The Rat Brain in Stereotaxic Coordinates, 3rd Edn. New York: Academic Press.
42. Pierce R. C., Meil W. M. and Kalivas P. W. (1997) The NMDA antagonist, dizocilpine, enhances cocaine reinforcement without influencing mesoaccumbens dopamine transmission. Psychopharmacology 133, 188-195.
43. Rabow L. E., Russek S. J. and Farb D. H. (1995) From ion currents to genomic analysis: recent advances in GABAA receptor research. Synapse 21, 189-274.
44. Riederer P., Lange K. W., Kornhuber J. and Danielczyk W. (1992) Glutamatergic - dopaminergic balance in the brain. Its importance in motor disorders and schizophrenia. Arzneimittelforschung 42, 265-268.
45. 3H]dopamine release from rat striatum: an in vitro model for glutamate actions. J. Neurochem. 32, 1539-1545.
46. 3H]dopamine from rat striatal slices. Brain Res. 157, 391-395.
47. Robinson T. E. and Berridge K. C. (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Rev. 18, 247-291.
48. Schmidt W. J., Bubser M. and Hauber W. (1992) Behavioural pharmacology of glutamate in the basal ganglia. J. Neural Transm. Suppl. 38, 65-89.
49. Segovia G., Porras A. and Mora F. (1997) Effects of 4-aminopyridine on extracellular concentrations of glutamate in striatum of the freely moving rat. Neurochem. Res. 22, 1491-1497.
50. Sesack S. R. and Pickel V. M. (1990) In the medial nucleus accumbens, hippocampal and catecholaminergic terminals converge on spiny neurons and are in apposition to each other. Brain Res. 527, 266-272.
51. Taepavarapruk P., Floresco S. B. and Phillips A. G. (2000) Hyperlocomotion and increased dopamine efflux in the rat nucleus accumbens evoked by electrical stimulation of the ventral subiculum: role of ionotropic glutamate and dopamine D1 receptors. Psychopharmacology 151, 242-251.
52. Wachtel H. and Turski L. (1990) Glutamate: a new target in schizophrenia? Trends Pharmacol. Sci. 11, 219-220.
53. Walters A., Jackson-Lewis V. and Fahn S. (1984) Little effect of dimethyl sulfoxide on blood-brain barrier to dopamine. Experientia 40, 859-861.
54. Weaver C. E., Jr Marek P., Park-Chung M., Tam S. W. and Farb D. H. (1997) Neuroprotective activity of a new class of steroidal inhibitors of the N-methyl-D-aspartate receptor. Proc. Natl Acad. Sci. USA 94, 10450-10454.
55. Weaver C. E. Jr, Wu F.-S., Gibbs T. T. and Farb D. H. (1998) Pregnenolone sulfate exacerbates NMDA-induced death of hippocampal neurons. Brain Res. 803, 129-136.
56. Westerink B. H. C., Hofsteede R. M., Tuntler J. and de Vries J. B. (1989) Use of calcium antagonism for the characterization of drug-evoked dopamine release from the brain of conscious rats determined by microdialysis. J. Neurochem. 52, 722-729.
57. Whitehead K. J., Rose S. and Jenner P. (2001) Involvement of intrinsic cholinergic and GABAergic innervation in the effect of NMDA on striatal dopamine efflux and metabolism as assessed by microdialysis studies in freely moving rats. Eur. J. Neurosci. 14, 851-860.
58. Whitton P. S., Maione S., Biggs C. S. and Fowler L. J. (1994) N-methyl-D-aspartate receptors modulate extracellular dopamine concentration and metabolism in rat hippocampus and striatum in vivo. Brain Res. 635, 312-316.
59. Wolf M. E. (1998) The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog. Neurobiol. 54, 679-720.
60. Wong M. and Moss R. L. (1994) Patch-clamp analysis of direct steroidal modulation of glutamate receptor-channels. J. Neuroendocrinol. 6, 347-355.
61. Wu F. S., Gibbs T. T. and Farb D. H. (1991) Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-D-aspartate receptor. Mol. Pharmacol. 40, 333-336.
62. Wu M., Brudzynski S. M. and Mogenson G. J. (1993) Functional interaction of dopamine and glutamate in the nucleus accumbens in the regulation of locomotion. Can. J. Physiol. Pharmacol 71, 407-413.
63. Yaghoubi N., Malayev A., Russek S. J., Gibbs T. T. and Farb D. H. (1998) Neurosteroid modulation of recombinant ionotropic glutamate receptors. Brain Res. 803, 153-160.
64. Zetterstrom T., Sharp T., Collin A. K. and Ungerstedt U. (1988) In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC. Eur. J. Pharmacol. 148, 327-334.